RhythmScience: Providing comprehensive cardiology software for remote cardiac care and management.
RhythmScience, founded to enhance access to scientific discoveries in cardiology, focuses on providing comprehensive remote cardiac care through advanced software solutions. Their core mission is to improve the management of hypertension, heart failure, and rhythm disorders by leveraging technology. Their flagship product, Rhythm360®, is an integrated platform designed to streamline workflows and deliver actionable data from various cardiac devices, including CIEDs, MCOTs, and EKGs. RhythmScience aims to revolutionize cardiac care by making critical cardiology data more accessible and manageable for healthcare providers.
Notable figures associated with RhythmScience include leading cardiologists and tech innovators who have contributed to its development and growth. The company has attracted significant investment from venture capital firms specializing in health tech. Key achievements include successful deployments of Rhythm360® in multiple healthcare settings, demonstrating improved patient outcomes and operational efficiencies. Overall, RhythmScience has made a substantial impact on the cardiology field by enabling more effective remote monitoring and management of cardiac conditions.
Companies similar to RhythmScience include Implicity, Rhythm Management Group, iRhythm and SafeBeat.
RhythmScience was founded in 2019.
RhythmScience's headquarters is located in San Francisco, CA, US.
RhythmScience's most recent funding round was for $6M (USD) in March 2023.
As of Mar 30, 2023, RhythmScience has disclosed funding of $6M (USD). Undisclosed round amounts are excluded.
RhythmScience has 28 employees as of Feb 5, 2024.
SafeBeat
safebeat.com
